BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 16377030)

  • 1. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
    Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
    J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence.
    Adler A; Yaniv I; Solter E; Freud E; Samra Z; Stein J; Fisher S; Levy I
    J Pediatr Hematol Oncol; 2006 Jan; 28(1):23-8. PubMed ID: 16394888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-related bloodstream infection in adult haematology patients: catheter removal practice and outcome.
    Coyle VM; McMullan R; Morris TC; Rooney PJ; Hedderwick S
    J Hosp Infect; 2004 Aug; 57(4):325-31. PubMed ID: 15262394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gram-negative bloodstream infections in hematopoietic stem cell transplant patients: the roles of needleless device use, bathing practices, and catheter care.
    Toscano CM; Bell M; Zukerman C; Shelton W; Novicki TJ; Nichols WG; Corey L; Jarvis WR
    Am J Infect Control; 2009 May; 37(4):327-34. PubMed ID: 19406332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.
    Raad I; Davis S; Becker M; Hohn D; Houston D; Umphrey J; Bodey GP
    Arch Intern Med; 1993 Aug; 153(15):1791-6. PubMed ID: 8392831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central venous catheter-associated bloodstream infections.
    Newman N; Issa A; Greenberg D; Kapelushnik J; Cohen Z; Leibovitz E
    Pediatr Blood Cancer; 2012 Aug; 59(2):410-4. PubMed ID: 22535579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tunnelled central venous catheters in children with cancer. Removal and duration].
    Schrøder H; Malchau E; Larsen LN; Bugge K; Olsen H; Kamperis K
    Ugeskr Laeger; 2008 Jan; 170(5):343-7. PubMed ID: 18252163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of implanted central venous catheters in neutropenic children.
    Elihu A; Gollin G
    Am Surg; 2007 Oct; 73(10):1079-82. PubMed ID: 17983086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
    Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
    Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
    Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
    J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients.
    Mirro J; Rao BN; Stokes DC; Austin BA; Kumar M; Dahl GV; Colten M; Balas L; Rafferty M; Hancock M
    J Clin Oncol; 1989 Feb; 7(2):214-22. PubMed ID: 2915237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term experiences with central venous catheters in pediatric oncology].
    Hadjilaskari P; Brühmüller S; Fengler R; Hartmann R; Waldschmidt J; Henze G
    Monatsschr Kinderheilkd; 1990 Jan; 138(1):26-30. PubMed ID: 2107396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Central venous totally implantable access for high dose chemotherapy in children].
    Conter C; Carausu L; Martin E; Rubie H; Castex MP; Marec-Berard P
    Arch Pediatr; 2006 Mar; 13(3):256-61. PubMed ID: 16469486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of septic complications associated with Silastic catheters in childhood malignancy.
    Hartman GE; Shochat SJ
    Pediatr Infect Dis J; 1987 Nov; 6(11):1042-7. PubMed ID: 3696842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious complications of peripherally inserted central venous catheters in children.
    Levy I; Bendet M; Samra Z; Shalit I; Katz J
    Pediatr Infect Dis J; 2010 May; 29(5):426-9. PubMed ID: 20016395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
    Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
    Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
    Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.
    Mancuso ME; Mannucci PM; Sartori A; Agliardi A; Santagostino E
    Br J Haematol; 2008 May; 141(5):689-95. PubMed ID: 18410458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.